venBio Select Advisor as of Sept. 30, 2016
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 44 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Sarepta Therapeutics (SRPT) | 17.1 | $100M | 1.6M | 61.41 | |
| BioMarin Pharmaceutical (BMRN) | 6.6 | $39M | 420k | 92.52 | |
| Lion Biotechnologies | 6.0 | $35M | 4.3M | 8.23 | |
| Agenus | 5.8 | $34M | 4.7M | 7.18 | |
| Tesaro | 4.7 | $28M | 278k | 100.24 | |
| Amicus Therapeutics (FOLD) | 4.7 | $27M | 3.7M | 7.40 | |
| Dermira | 4.6 | $27M | 806k | 33.82 | |
| ACADIA Pharmaceuticals (ACAD) | 4.3 | $25M | 793k | 31.81 | |
| Neurocrine Biosciences (NBIX) | 4.2 | $25M | 491k | 50.64 | |
| Immunomedics | 4.2 | $25M | 7.6M | 3.25 | |
| Bristol Myers Squibb (BMY) | 3.7 | $22M | 400k | 53.92 | |
| Global Blood Therapeutics In | 3.4 | $20M | 869k | 23.05 | |
| Aerie Pharmaceuticals | 3.2 | $19M | 500k | 37.74 | |
| Gw Pharmaceuticals Plc ads | 3.0 | $18M | 134k | 132.73 | |
| Vanda Pharmaceuticals (VNDA) | 2.3 | $14M | 828k | 16.64 | |
| Neuroderm Ltd F | 2.2 | $13M | 686k | 18.49 | |
| Teligent | 2.1 | $12M | 1.6M | 7.60 | |
| Sorrento Therapeutics (SRNE) | 2.0 | $12M | 1.5M | 7.74 | |
| Mirati Therapeutics | 1.7 | $9.8M | 1.5M | 6.61 | |
| Cascadian Therapeutics | 1.6 | $9.2M | 5.6M | 1.64 | |
| Akebia Therapeutics (AKBA) | 1.5 | $8.5M | 945k | 9.05 | |
| Agios Pharmaceuticals (AGIO) | 1.4 | $7.9M | 150k | 52.82 | |
| Seattle Genetics | 1.3 | $7.6M | 142k | 54.01 | |
| Veracyte (VCYT) | 1.2 | $7.0M | 919k | 7.61 | |
| BioCryst Pharmaceuticals (BCRX) | 1.0 | $6.1M | 1.4M | 4.41 | |
| Alimera Sciences | 0.9 | $5.3M | 3.6M | 1.49 | |
| Trillium Therapeutics, Inc. Cmn | 0.8 | $4.7M | 316k | 14.78 | |
| Corvus Pharmaceuticals (CRVS) | 0.8 | $4.4M | 268k | 16.45 | |
| Fortress Biotech | 0.7 | $4.0M | 1.4M | 2.97 | |
| Proteostasis Therapeutics In | 0.5 | $2.8M | 180k | 15.59 | |
| Innocoll Hldgs | 0.5 | $2.7M | 468k | 5.81 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.3 | $2.0M | 7.0M | 0.29 | |
| Assembly Biosciences | 0.3 | $1.9M | 268k | 7.21 | |
| Oncobiologics | 0.3 | $1.9M | 451k | 4.25 | |
| Cellectis S A (CLLS) | 0.2 | $1.4M | 59k | 24.08 | |
| Versartis | 0.2 | $1.2M | 96k | 12.25 | |
| Oncomed Pharmaceuticals | 0.2 | $972k | 85k | 11.44 | |
| Ascendis Pharma A S (ASND) | 0.1 | $909k | 45k | 20.11 | |
| Cempra | 0.1 | $726k | 30k | 24.20 | |
| Vericel (VCEL) | 0.1 | $604k | 216k | 2.80 | |
| Nantkwest | 0.1 | $563k | 72k | 7.77 | |
| Dicerna Pharmaceuticals | 0.1 | $271k | 46k | 5.88 | |
| Oncobiologics Inc *w exp 05/18/201 | 0.0 | $233k | 233k | 1.00 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $112k | 233k | 0.48 |
